FIELD: biotechnologies.
SUBSTANCE: described strain is produced by performance of a series of adaptation passages of a parent strain of the virus ZhEV-15 Coxsackie B6 on the culture of cells HEK293 highly sensitive to this virus and the neoplastic cell line C33A (HPV-negative carcinoma of human uterine neck), with production of a new strain ZhEV-15L of the virus Coxsackie B6. The strain selectively infects and lyses tumorous human cells and has a fragment of a genome sequence represented in the dwg. 2, being its marker criterion. The strain is deposited in the State Collection of the Federal Service for Oversight of Consumer Protection and Welfare of agents of viral infections and rickettsial diseases of the Federal Budget Institution of Science State Science Centre of Virusology and Biotechnology "Vector" under the registration number V-576.
EFFECT: invention provides for the possibility of promising development of a viral oncolytic preparation on its basis for therapy of malignant human tumours and definition of a full nucleotide sequence of its genome.
3 dwg, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
STRAIN OF ENTEROVIRUS A71 OF SUBGENOTYPE TYPE C4 USED FOR DIAGNOSTICS AND STUDY OF EFFICIENCY OF MEDICAL AND PREVENTIVE AND VACCINAL PREPARATIONS | 2014 |
|
RU2565811C1 |
NON-PATHOGENIC STRAIN LEV82 OF HUMAN ENTEROVIRUS A, COXSACKIE SEROTYPE A7, FOR NON-SPECIFIC PREVENTION OF VIRAL INFECTIONS AND TREATMENT OF ONCOLOGICAL DISEASES | 2024 |
|
RU2824819C1 |
METHOD FOR CULTIVATION OF FETAL PORCINE CELLS FOR VIROLOGY | 2021 |
|
RU2795135C2 |
NEWCASTLE DISEASE NDVH-2 VIRUS STRAIN FOR STUDY OF POSSIBILITY OF VIRAL ONCOLYTIC PREPARATION DEVELOPMENT ON ITS BASIS | 2016 |
|
RU2644676C1 |
ANTI-ENTEROVIRAL AND IMMUNOSTIMULATING AGENT | 2014 |
|
RU2554761C1 |
METHOD FOR AMPLIFYING THE VP1 REGION OF THE GENOME OF ENTEROVIRUS SPECIES ENTEROVIRUS B | 2021 |
|
RU2774424C1 |
METHOD FOR OBTAINING VIRUS-LIKE PARTICLES OF NOROVIRUS CONTAINING THE PROTEIN VP1 OF ENTEROVIRUS ECHOVIRUS 30, IN VITRO | 2022 |
|
RU2789354C1 |
SET OF SYNTHETIC OLIGONUCLEOTIDE PRIMERS FOR OBTAINING FULL NUCLEOTIDE SEQUENCE OF VP1 GENE OF COXSACKIE A10 ENTEROVIRUS | 2020 |
|
RU2762236C1 |
ALLERGIC SENSITISATION PREVENTION | 2008 |
|
RU2429881C2 |
RECOMBINANT PLASMID DNA pcDNA4-Apo-2NLS2 CARRYING SYNTHETIC GENE OF APOPTIN PROTEIN INDUCING p53-INDEPENDENT PROGRAMMED TUMOUR CELL DEATH | 2013 |
|
RU2541777C1 |
Authors
Dates
2013-10-27—Published
2012-06-04—Filed